Cardiac Drugs Study Guide Course
Cardiac Drugs Study Guide Course
Cardiac Drugs Study Guide Course
To divert blood to the important organs ❖ Monitor BP, heart rate, ECG,
stimulates the sympathetic nervous system via cardiac output, CVP, and urinary
vasoconstriction. This will also increase BP and output continuously.
perfusion. ❖ Report significant changes in vital
signs or arrhythmias.
Why do we give it? “Reason” ❖ Palpate peripheral pulses and
❖ Hypovolemic shock assess appearance of extremities
❖ Severe hypotension routinely.
❖ Superficial bleeding ❖ Notify physician if quality of pulse
❖ Cardiac decomp/ arrest deteriorates or if extremities
❖ Allergic reactions become cold or mottled.
❖ Ventricular arrhythmia ❖ Lab Test Considerations:
❖ Respiratory distress Monitor potassium
❖ Glaucoma concentrations during therapy;
❖ Adjunct to local anesthetic may cause hypokalemia.
❖ Bronchodilators ❖ Monitor electrolytes, BUN,
creatinine, and prothrombin time
Adverse Effects weekly during prolonged therapy.
CV: increase blood pressure to dangerously
high levels. Interactions
Derm: dopamine can cause necrosis of the ❖ Antidepressants: increase
vein. adrenergic effects.
❖ Oxytocin: increases the risk for
hypertension.
Contraindications
Dopamine: pheochromocytoma, v fib ,
arrhythmia.
Simple nursing Brain Bits
Epinephrine: narrow angle glaucoma,
❖ These are the drugs you will mostly see
anesthetic for fingers and toes (no no) in a CODE situation.
Norepinephrine: hypotension from blood loss, ❖ When giving epi do not administer in
Midodrine: causes severe hypertension when fingers and toes it can cause severe
the patient is lying down. vasoconstriction and cause the area to
become ischemic.
Epinephrine Adrenalin 0.1– 0.5 mg (single dose) IM, sub Q ,IV push
Propranolol Inderal, Inderal LA, 80– 320 mg/day in 2– 4 divided PO, IV , PO-ER
InnoPran XL doses
Metoprolol: lopressor lopressor 25– 100 mg/day as a single dose PO, IV , PO-ER
Contraindications Interactions
❖ Central:Hepatic disease ( active ) , MAOI ❖ Adrenergic: risk of HTN
antidepressant therapy ❖ Levodopa: hypotension,
❖ Peripheral: ulcerative colitis , peptic ulcer decrease levodopa
❖ Anesthetic agents: increase
anesthetic
❖ Beta blockers: hypertension
❖ Lithium: lithium toxicity
❖ Haloperidol: psychotic behavior
Contraindications
❖ Hypersensitivity
❖ Electrolyte imbalances
❖ severe kidney or liver dysfunction
❖ Anuria.
❖ Mannitol: active intracranial bleeding except
during craniotomy Simple Nursing Brain bits
Taking this medication early in the day
can prevent injury r/t getting out of bed
at night for the client.
Adverse Effects
CNS:confusion, headache.
EENT: blurred vision, rhinitis.
CV: transient volume expansion, chest pain,
HF, pulmonary edema, tachycardia.
GI: nausea, thirst, vomiting.
GU: renal failure, urinary retention.
F and E: dehydration, hyperkalemia, Simple Nursing Brain Bits
hypernatremia, hypokalemia, hyponatremia.
Local: phlebitis at IV site. Symptoms of fluid and electrolyte
imbalance include dry mouth, thirst,
Contraindications weakness, lethargy, drowsiness,
❖ Mannitol: active intracranial bleeding restlessness confusion, muscle pain or
except during craniotomy cramps, confusion, gastrointestinal
❖ Hypersensitivity disturbances, hypotension, oliguria,
❖ Anuria tachycardia, and seizures.
❖ Dehydration
❖ Severe pulmonary edema or congestion.
Simplenursing.com
How it works “ Action”
Oral and parenteral anticoagulants Nursing management
Are used to prevent the formation and extension of a ❖ Assess for signs of bleeding and hemorrhage
thrombus but do not help with an active clot or embolus (bleeding gums; nose bleed; unusual
bruising; black, tarry stools; hematuria; fall
in hematocrit or BP; guaiac-positive stools).
❖ Heparin inhibits the formation of fibrin clots, Notify health care professional if these occur.
inhibits conversion of fibrinogen to fibrin and ❖ SQ: Observe injection sites for hematomas,
inactivated several clotting factors. ecchymosis, or inflammation.
❖ Lab Test Considerations: Monitor activated
partial thromboplastin time (aPTT) and
hematocrit before and after and periodically.
Why do we give it? “Reason” When intermittent IV therapy is used, draw
❖ Prevention of DVT, aPTT levels 30 min before each dose during
❖ Prevention of A-FIB with embolization initial therapy and then periodically.
❖ prevention of clotting in arterial heart surgery ❖ During continuous administration, monitor
aPTT levels every 4 hr during early therapy.
❖ Prevention and treatment of PE, prevention of
❖ SQ therapy: Draw blood 4– 6 hr after
repeat cerebral thrombosis injection. Monitor platelet count every 2– 3
❖ Adjuvant treatment of MI days throughout therapy.
❖ treatment of coronary occlusion,acute MI,
peripheral arterial embolism
❖ Prevention of thrombus formation after valve
Interactions
❖ Nsaids/aspirin: increased risk for
replacement bleeding
❖ Diagnosis of disseminated intravascular ❖ PCN/aminoglycoside/increased risk for
coagulation bleeding
❖ Maintain patency of iv catheter ❖ Beta blocker/loop Diuretics : increased
risk for bleeding
❖ Disulfiram/cimetidine; increased risk
Adverse Effects for bleeding
GI: Drug-induced hepatitis ❖ Oral contraceptive/
Derm: alopecia (long-term use), rashes, urticaria barbiturates/diuretics: decreased
Hemat: BLEEDING, HEPARIN-INDUCED effects of anticoagulant
THROMBOCYTOPENIA (HIT) (WITH OR WITHOUT
THROMBOSIS), anemia.
Local: Pain at injection site.
MS: Osteoporosis (long-term use)
.Misc: Fever, hypersensitivity
Contraindications
❖ Uncontrolled bleeding
❖ Severe thrombocytopenia; hemorrhagic disease
❖ Open wounds (full dose). Simple Nursing Brain bits
❖ Pork allergy ❖ Heparin can’t be taken orally,
❖ TB gastric acids inactive it, given
❖ Hemorrhagic disease injection only!
❖ Leukemia
Simplenursing.com
How it works “ Action”
These drugs work by decreasing the platelets’ ability to stick together Nursing management
(aggregate ) in the blood, thus forming a clot. ❖ Assess for signs of bleeding and hemorrhage
Aspirin works by prohibiting the aggregation of the platelets for the
(bleeding gums; nose bleed; unusual
lifetime of the platelet. The ADP blockers alter the platelet cell
membrane, preventing aggregation. Glycoprotein receptor blockers bruising; black, tarry stools; hematuria; fall
work to prevent enzyme production, again inhibiting platelet in hematocrit or BP; guaiac-positive stools).
aggregation. Notify health care professional if these occur.
❖ SQ: Observe injection sites for hematomas,
ecchymosis, or inflammation.
Why do we give it? “Reason” ❖ Lab Test Considerations: Monitor activated
❖ Antiplatelet drug therapy is designed primarily to treat partial thromboplastin time (aPTT) and
patients at risk for acute coronary syndrome, MI, stroke, and hematocrit before and after and periodically.
intermittent claudication. When intermittent IV therapy is used, draw
aPTT levels 30 min before each dose during
initial therapy and then periodically.
Adverse Effects ❖ During continuous administration, monitor
❖ Heart palpitations aPTT levels every 4 hr during early therapy.
❖ Bleeding
❖ Dizziness and headache
❖ SQ therapy: Draw blood 4– 6 hr after
❖ Nausea, diarrhea, constipation, dyspepsia injection. Monitor platelet count every 2– 3
days throughout therapy.
Interactions
Contraindications ❖ Aspirin and NSAID: Increased risk of
bleeding
❖ Pregnancy ❖ Macrolide antibiotics: Increased
❖ Lactation effectiveness of anti-infective
❖ Congestive heart failure ❖ Digoxin: Decreased digoxin serum levels
❖ Active bleeding ❖ Phenytoin: Increased phenytoin serum levels
❖ Thrombotic thrombocytopenic purpura
Clopidogrel plavix Recent MI, stroke, and Single loading dose: 300
acute coronary syndrome mg; 75 mg/day orally
Simplenursing.com
How it works “ Action”
these drugs break down fibrin clots by converting plasminogen to Nursing management
plasmin. Plasmin is an enzyme that breaks down the fibrin of a blood ❖ Must administer within 4-6 hours post
clot. This reopens blood vessels after their occlusion and prevents thrombus formation
tissue necrosis. ❖ Assess the patient for bleeding every 15
minutes during the first 60 minutes of
therapy, every 15 to 30 minutes for the next 8
Why do we give it? “Reason” hours, and at least every 4 hours until therapy
❖ Acute stroke or MI by lysis (breaking up) of blood clots in the is completed. Vital signs are monitored
coronary arteries continuously. If pain is present, the primary
❖ Blood clots causing pulmonary emboli and DVT health care provider may order an opioid
analgesic. Once the clot dissolves and blood
❖ Suspected occlusions in central venous catheters (Ford 394)
flows freely through the obstructed blood
vessel, severe pain usually decreases. (Ford
396)
Adverse Effects
❖ Bleeding ❖ Lab Test Considerations: Monitor activated
partial thromboplastin time (aPTT) and
hematocrit before and after and periodically.
When intermittent IV therapy is used, draw
Contraindications aPTT levels 30 min before each dose during
❖ Active bleeding initial therapy and then periodically.
❖ History of stroke ❖ During continuous administration, monitor
❖ History of aneurysm aPTT levels every 4 hr during early therapy.
❖ Recent intracranial surgery
Interactions
❖ When a thrombolytic is administered with
medications that prevent blood clots, such
as aspirin, dipyridamole, or an anticoagulant,
the patient is at increased risk for bleeding.
alteplase Activase, Cathflo Activase (for IV Acute MI, acute ischemic stroke, Total dose of 90–100 mg IV,
catheter occlusions only) PE, IV catheter clearance given as a 2- to 3-hr infusion
Simplenursing.com
Nursing management
How it works “ Action” ❖ The dose of sublingual nitroglycerin may be repeated every 5
minutes until pain is relieved or until the patient has received
The nitrates act by relaxing the smooth muscle layer
three doses in a 15-minute period. One to two sprays of
of blood vessels, increasing the lumen of the artery
translingual nitroglycerin may be used to relieve angina, but no
or arteriole, and increasing the amount of blood
more than three metered doses are recommended within a
flowing through the vessels. (Ford 382)
15-minute period.
❖ Do not rub the nitroglycerin ointment into the patient’s skin,
because this will immediately deliver a large amount of the
drug through the skin. Exercise care in applying topical
nitroglycerin and do not allow the ointment to come in contact
with your fingers or hands while measuring or applying the
Why do we give it? “Reason” ointment, because the drug will be absorbed through your skin,
causing a severe headache.
❖ Relieve pain of acute anginal attacks
❖ The primary health care provider is notified if any of the
❖ Prevent angina attacks (prophylaxis )
following occur:
❖ Treat chronic stable angina pectoris (Ford
❖ Heart rate of 20 bpm or more above the normal rate
382)
❖ Rapid weight gain of 5 lb or more
❖ Unusual swelling of the extremities, face, or abdomen
Adverse Effects ❖ Dyspnea, angina, severe indigestion, or fainting
❖ Central nervous system (CNS) reactions, such as ❖ Avoid the use of alcohol unless use has been permitted by the
headache (may be severe and persistent), primary health care provider.
dizziness, weakness, and restlessness ❖ Notify your emergency response providers if the drug does not
❖ Other body system reactions, such as relieve pain or if pain becomes more intense despite use of this
hypotension, flushing (caused by dilation of small
drug.
capillaries near the surface of the skin), and rash
(Ford 382) ❖ Follow the recommendations of the primary health care
❖ provider regarding frequency of use.
❖ Keep an adequate supply of the drug on hand for events, such
as vacations, bad weather conditions, and holidays.
❖ Keep a record of the frequency of acute anginal attacks (date,
Contraindications time of the attack, drug, and dose used to relieve the acute
pain), and bring this record to each primary health care
❖ hypersensitivity to the drugs, severe anemia, provider or clinic visit.
closed-angle glaucoma, postural hypertension, early
myocardial infarction (sublingual form), head trauma,
cerebral hemorrhage (may increase intracranial
hemorrhage), allergy to adhesive (transdermal system), Interactions
or constrictive pericarditis. Patients taking
phosphodiesterase inhibitors (drugs for erectile
dysfunction) should not use nitrates. (Ford 382)
❖ Aspirin: Increased nitrate plasma concentrations and action may
occur
❖ calcium channel blockers:Increased symptomatic orthostatic
hypotension
❖ Dihydroergotamine: Increased risk of hypertension and decreased
antianginal effect
❖ Heparin: Decreased effect of heparin
❖ phosphodiesterase inhibitors: Severe hypotension and
cardiovascular collapse may occur
❖ Alcohol: Severe hypotension and cardiovascular collapse may occur
Simplenursing.com
How it works “ Action” Nursing management
Systemic and coronary arteries are influenced ❖ Monitor BP and pulse frequently
by Ca++ moving across cell membranes. ❖ Monitor intake and output ratios
CCB act by inhibiting the movement of calcium and daily weight. Assess for signs
across the cell membrane of cardiac and of HF (peripheral edema,
arterial muscles. Resulting in less calcium rales/crackles, dyspnea, weight
available for nerve impulse transmission and gain, jugular venous distention).
relax blood vessels to increase 02 supply to ❖ Angina: Assess location,
decrease cardiac workload duration, intensity, and
precipitating factors of patient’s
Why do we give it? “Reason” anginal pain
❖ Hypertension ❖ Avoid large amounts (6– 8
❖ Angina pectoris glasses of grapefruit juice/day)
❖ Vasospastic (Prinzmetal’s) angina ❖ Have the client check pulse and
report any sudden changes
Adverse Effects
CNS: dizziness, fatigue. Interactions
CV: peripheral edema, angina, bradycardia, ❖ Cimetidine: increase effects of
hypotension, palpitations. CCB
GI: gingival hyperplasia, nausea. ❖ Theophylline: toxic effects of
Derm: flushing theophylline
Contraindications ❖ Digoxin: Dig toxicity
❖ Calcium channel blockers: sick sinus ❖ Rifampin: decreased CCB effects
syndrome, 2nd/3rd degree
atrioventricular block, ventricular
dysfunction, cardiogenic shock.
Contraindications
❖ digitalis toxicity
❖ known hypersensitivity
❖ ventricular failure, ventricular tachycardia, cardiac
tamponade, restrictive cardiomyopathy, or AV block. (Ford
Digoxin toxicity & electrolyte imbalances
Plasma digoxin levels are monitored closely. Blood for plasma level
404)
measurements should be drawn immediately before the next dose or 6 to 8
hours after the last dose regardless of route. Therapeutic drug levels are
between 0.8 and 2 nanograms/mL. Plasma digoxin levels greater than 2
nanograms/mL are considered toxic and are reported to the primary health
care provider
Hypokalemia makes the heart muscle more sensitive to digitalis, thereby
increasing the possibility of developing digitalis toxicity. At frequent intervals,
observe patients with hypokalemia closely for signs of digitalis toxicity. (Ford
405)
digoxin Lanoxin Heart failure, atrial fibrillation Loading dose:* 0.75–1.25 mg orally or 0.6–1
mg IV
Maintenance: 0.125–0.25 mg/day orally
Lanoxicaps: 0.1–0.3 mg/day orally